DUROLANE

Learn more about DUROLANE

To learn more about DUROLANE or for general enquiries, please contact;

J.O. Corporation
4F., NO. 88-5., Minquan Rd., Xindian Dist.,
New Taipei City 231,
Taiwan

Contact details
T: (886-2) 8219 1578
F: (886-2) 2218 5362
W: www.jocorp.com.tw

Bioventus
Summary of Indications for Use
DUROLANE (3 mL): Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. Full prescribing information can be found in product labeling.

There are no known contraindications.

You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children.
Risks can include transient pain, swelling and/or stiffness at the injection site.

Full prescribing information can be found in Product Labeling.

DUROLANE, Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC. NASHA is a registered trademark of Nestlé Skin Health S.A.

© 2017 Bioventus LLC.

Durolane-since-2001
*First introduced in the European Union in 2001.

To learn more about DUROLANE or for contact information, please select your location to continue.

I would like to receive more information about DUROLANE.

Osteoarthritis: The Ongoing Challenges to Manage Pain

https://player.vimeo.com/video/125047428

Contact us for additional information